Deletion of Chromosomes 13q and 14q Is a Common Feature of Tumors with BRCA2 Mutations

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Rouault, Audrey ^a   Banneau, Guillaume ^a   MacGrogan, Gaëtan ^a,b   Jones, Natalie ^a   Elarouci, Nabila ^c   Barouk Simonet, Emmanuelle ^b   Venat, Laurence ^d   Coupier, Isabelle ^e   Letouzé, Eric ^c   de Reyniès, Aurélien ^c   Bonnet, Françoise ^a,b   Iggo, Richard ^a   Sévenet, Nicolas ^a,b   Longy, Michel ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSTITUT BERGONIÉ   (France)

^c Programme Cartes d'Identite des Tumeurs CIT   (France)

^d DUPUYTREN UNIVERSITY HOSPITAL   (France)

^e CENTRE VAL D AURELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BIOINFORMATICS; BREAST TUMOR; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME DELETION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEASIBILITY STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MUTATION; GENETIC SCREENING; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; VALIDATION PROCESS;

ADULT; AGED; BREAST NEOPLASMS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 14; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 84871349231     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052079     Document Type: Article

References (28)

1. Walsh T, King MC, (2007) Ten genes for inherited breast cancer. Cancer Cell 11: 103-105.
2. Fackenthal JD, Olopade OI, (2007) Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer 7: 937-948.
3. Collins N, McManus R, Wooster R, Mangion J, Seal S, et al. (1995) Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 10: 1673-1675.
4. Boulton SJ, (2006) Cellular functions of the BRCA tumour-suppressor proteins. Biochem Soc Trans 34: 633-645.
5. Greenberg RA, Sobhian B, Pathania S, Cantor SB, Nakatani Y, et al. (2006) Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. Genes Dev 20: 34-46.
6. Yang H, Li Q, Fan J, Holloman WK, Pavletich NP, (2005) The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA-ssDNA junction. Nature 433: 653-657.
7. Stefansson OA, Jonasson JG, Johannsson OT, Olafsdottir K, Steinarsdottir M, et al. (2009) Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes. Breast Cancer Res 11: R47.
8. Moller P, Hagen AI, Apold J, Maehle L, Clark N, et al. (2007) Genetic epidemiology of BRCA mutations-family history detects less than 50% of the mutation carriers. Eur J Cancer 43: 1713-1717.
9. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98: 10869-10874.
10. Banneau G, Guedj M, Macgrogan G, de Mascarel I, Velasco V, et al. (2010) Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations. Breast Cancer Res 12: R63.
11. R Core Team (2012) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org/. Accessed 2012 Nov 22.
12. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
13. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
14. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
15. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
16. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273.
17. Eisen MB, Spellman PT, Brown PO, Botstein D, (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868.
18. CAPweb. Copy number Array analysis Platform on the web: A web-based platform for copy number array management and analysis, version 2.4, Available: http://bioinfo-out.curie.fr/CAPweb/. Accessed 2012 Nov 22.
19. Waddell N, Arnold J, Cocciardi S, da Silva L, Marsh A, et al. (2010) Subtypes of familial breast tumours revealed by expression and copy number profiling. Breast Cancer Res Treat 123: 661-677.
20. Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, et al. (2001) Gene-expression profiles in hereditary breast cancer. N Engl J Med 344: 539-548.
21. Jonsson G, Naylor TL, Vallon-Christersson J, Staaf J, Huang J, et al. (2005) Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization. Cancer Res 65: 7612-7621.
22. Jonsson G, Staaf J, Vallon-Christersson J, Ringner M, Holm K, et al. (2010) Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics. Breast Cancer Res 12: R42.
23. Joosse SA, Brandwijk KI, Devilee P, Wesseling J, Hogervorst FB, et al. (2012) Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH. Breast Cancer Res Treat 132: 379-389.
24. Tirkkonen M, Johannsson O, Agnarsson BA, Olsson H, Ingvarsson S, et al. (1997) Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res 57: 1222-1227.
25. Tischkowitz M, Xia B, Sabbaghian N, Reis-Filho JS, Hamel N, et al. (2007) Analysis of PALB2/FANCN-associated breast cancer families. Proc Natl Acad Sci U S A 104: 6788-6793.
26. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, et al. (2007) Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci U S A 104: 20007-20012.
27. Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, et al. (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434: 913-917.
28. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, et al. (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434: 917-921.